239 related articles for article (PubMed ID: 20221656)
1. Recent developments in innervation imaging using iodine-123-metaiodobenzylguanidine scintigraphy in Lewy body diseases.
Treglia G; Cason E; Gabellini A; Giordano A; Fagioli G
Neurol Sci; 2010 Aug; 31(4):417-22. PubMed ID: 20221656
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
Orimo S
Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
[TBL] [Abstract][Full Text] [Related]
3. [The clinical significance of MIBG myocardial scintigraphy in Parkinson disease].
Orimo S
Brain Nerve; 2012 Apr; 64(4):403-12. PubMed ID: 22481513
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders.
King AE; Mintz J; Royall DR
Mov Disord; 2011 Jun; 26(7):1218-24. PubMed ID: 21480373
[TBL] [Abstract][Full Text] [Related]
5. 123I-metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders.
Rascol O; Schelosky L
Mov Disord; 2009; 24 Suppl 2():S732-41. PubMed ID: 19877202
[TBL] [Abstract][Full Text] [Related]
6. A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies.
Yoshita M; Taki J; Yamada M
J Neurol Neurosurg Psychiatry; 2001 Nov; 71(5):583-8. PubMed ID: 11606666
[TBL] [Abstract][Full Text] [Related]
7. The role of 123I-metaiodobenzylguanidine myocardial scintigraphy in the diagnosis of Lewy body disease in patients with dementia in a memory clinic.
Hanyu H; Shimizu S; Hirao K; Sakurai H; Iwamoto T; Chikamori T; Hida S; Yamashina A; Koizumi K; Abe K
Dement Geriatr Cogn Disord; 2006; 22(5-6):379-84. PubMed ID: 16960446
[TBL] [Abstract][Full Text] [Related]
8. Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders: it can be a specific marker for Lewy body disease.
Taki J; Yoshita M; Yamada M; Tonami N
Ann Nucl Med; 2004 Sep; 18(6):453-61. PubMed ID: 15515743
[TBL] [Abstract][Full Text] [Related]
9. (123)I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in α-synucleinopathies.
Orimo S; Yogo M; Nakamura T; Suzuki M; Watanabe H
Ageing Res Rev; 2016 Sep; 30():122-33. PubMed ID: 26835846
[TBL] [Abstract][Full Text] [Related]
10. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease.
Suzuki M; Kurita A; Hashimoto M; Fukumitsu N; Abo M; Ito Y; Urashima M; Inoue K
J Neurol Sci; 2006 Jan; 240(1-2):15-9. PubMed ID: 16199056
[TBL] [Abstract][Full Text] [Related]
11. MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis.
Treglia G; Cason E; Stefanelli A; Cocciolillo F; Di Giuda D; Fagioli G; Giordano A
Clin Auton Res; 2012 Feb; 22(1):43-55. PubMed ID: 21792729
[TBL] [Abstract][Full Text] [Related]
12. Iodine-123-MIBG sympathetic imaging in Lewy-body diseases and related movement disorders.
Nakajima K; Yoshita M; Matsuo S; Taki J; Kinuya S
Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):378-87. PubMed ID: 19088692
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of rCBF analysis in diagnosing Parkinson's disease: supplemental role with MIBG myocardial scintigraphy.
Nagamachi S; Wakamatsu H; Kiyohara S; Fujita S; Futami S; Tamura S; Nakazato M; Yamashita S; Arita H; Nishii R; Kawai K
Ann Nucl Med; 2008 Aug; 22(7):557-64. PubMed ID: 18756357
[TBL] [Abstract][Full Text] [Related]
14. [The clinical value of
Liu W; Yao X; Ou X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2023 Jun; 40(3):595-601. PubMed ID: 37380402
[TBL] [Abstract][Full Text] [Related]
15. Scintigraphic differentiation between two forms of primary dysautonomia early after onset of autonomic dysfunction: value of cardiac and pulmonary iodine-123 MIBG uptake.
Reinhardt MJ; Jüngling FD; Krause TM; Braune S
Eur J Nucl Med; 2000 May; 27(5):595-600. PubMed ID: 10853817
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity and specificity of cardiac
Kawazoe M; Arima H; Maeda T; Tsuji M; Mishima T; Fujioka S; Tsugawa J; Tsuboi Y
J Neurol Sci; 2019 Dec; 407():116409. PubMed ID: 31706063
[TBL] [Abstract][Full Text] [Related]
17. Preserved myocardial [123I]metaiodobenzylguanidine uptake in autosomal recessive juvenile parkinsonism: first case report.
Suzuki M; Hattori N; Orimo S; Fukumitsu N; Abo M; Kono Y; Sengoku R; Kurita A; Honda H; Inoue K
Mov Disord; 2005 May; 20(5):634-6. PubMed ID: 15704207
[TBL] [Abstract][Full Text] [Related]
18. [Cardiac sympathetic innervation imaging with myocardial MIBG scintigraphy].
Genovese EA; Mallardo V; Cipullo S; Restuccia A; Galea D; D'Agosto G; Di Lanno I; Cappabianca S
Recenti Prog Med; 2013; 104(7-8):356-60. PubMed ID: 24042407
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of dementia with Lewy bodies, Alzheimer's disease and vascular dementia by cardiac 131I-meta-iodobenzylguanidine (MIBG) uptake (preliminary report).
Jindahra P; Vejjajiva A; Witoonpanich R; Sirisriro R; Sritara C; Pulkes T
J Med Assoc Thai; 2004 Oct; 87(10):1176-81. PubMed ID: 15560694
[TBL] [Abstract][Full Text] [Related]
20. [123I-metaiodobenzylguanidine myocardial scintigraphy in the differential diagnosis of patients with parkinsonian syndromes -- case reports].
Leńska-Mieciek M; Derecka-Charzyńska I; Fiszer U; Królicki L; Kułakowski P
Neurol Neurochir Pol; 2005; 39(5):424-8. PubMed ID: 16273470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
